naftopidil has been researched along with Anesthesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoyano, Y; Kobayashi, S; Kohri, K; Sasaki, S; Tomiyama, Y; Yamazaki, Y | 1 |
| Asano, T; Ikegaki, I; Shibata, K; Takei, R; Tsujimoto, G | 1 |
2 other study(ies) available for naftopidil and Anesthesia
| Article | Year |
|---|---|
Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Cardiovascular System; Dogs; Dose-Response Relationship, Drug; Indoles; Male; Naphthalenes; Piperazines; Ureter; Ureteral Calculi | 2010 |
Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthesia; Animals; Binding, Competitive; Blood Pressure; CHO Cells; Cricetinae; Dogs; Humans; Male; Naphthalenes; Phenethylamines; Phenylephrine; Piperazines; Pressure; Prostate; Radioligand Assay; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Tetralones | 1999 |